Villarin, Romeo .

HRN: 26-35-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/21/2024
12/27/2024
IV
500mg
Q6h
H Pylori Infection
Waiting Final Action 

Indication:  Culture-directed    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: